Guides / Wegovy (semaglutide)

How to Appeal a Wegovy (Semaglutide) Denial

Denied Wegovy? It is FDA-approved for chronic weight management and for reducing cardiovascular risk in adults with heart disease and obesity — and that heart-health indication is a powerful, underused appeal angle.

Your deadline: most plans allow 180 days from the date on your denial letter to file an internal appeal — more time than most people think. Check the date on your letter.

Why Wegovy (semaglutide) claims get denied

Formulary exclusion — some plans exclude weight-loss drugs entirely (check this first, below)
Step therapy — try a different agent first
BMI or comorbidity criteria not documented
Framed as "cosmetic" rather than medical

Before appealing, check your plan’s prescription drug list. If weight-loss medications are excluded (not covered under any circumstances) rather than denied, a medical-necessity appeal cannot win — that is a benefit-design issue, not a coverage decision. Our free check tells you which one you’re facing before you spend anything.

The argument that wins

Use the cardiovascular indication: Wegovy is FDA-approved to reduce the risk of major cardiovascular events (heart attack, stroke) in adults with established cardiovascular disease and obesity or overweight. If you have heart disease, this is medical necessity well beyond weight.
Document your comorbidities — prediabetes, hypertension, high cholesterol — to support medical necessity.
Request a step-therapy exception if the plan requires another drug first and there is a clinical reason it is inappropriate for you.

Evidence to gather

Your BMI and weight history
Documentation of established cardiovascular disease, if applicable
Comorbidity documentation: A1c, blood pressure, lipid panel
Records of prior weight-loss drugs tried and their outcomes
A letter of medical necessity from your prescriber

Related appeal guides

Want this done for you?

Run a free case check — we read your denial, tell you if it’s appealable, and only charge ($149 flat) if it is. Expert-reviewed appeal in 2 business days.

Check my denial — free

Frequently asked questions

I have heart disease — does that strengthen my Wegovy appeal?

Yes. Wegovy is FDA-approved to reduce cardiovascular events in adults with established heart disease and obesity or overweight. Documenting your cardiac history reframes the request as cardiovascular risk reduction, not weight loss alone.

My plan excludes weight-loss drugs — can I still appeal?

A blanket weight-loss exclusion generally cannot be overturned on medical necessity. But if you qualify under the cardiovascular indication, that may fall outside a pure weight-loss exclusion — worth checking. Our free case check reviews this.